An interventional study of Wearable hip assist robot in Gait, Unsteady and Health Behavior, sponsored by Samsung Medical Center. Completed at 1 site in Korea, Republic of. Open to participants aged 65 Years to 84 Years. Per ClinicalTrials.gov, last updated 2018-01-03.
Sponsored by Samsung Medical Center · Not applicable, Interventional, and Other
Among 15 studies in Gait Disorders, Neurologic with a site in Korea, Republic of — 3 open to participants now, 4 under way, none of them phase 3. Gait Disorders, Neurologic · Korea, Republic of.
Among the 15 studies in Gait Disorders, Neurologic with a site in Korea, Republic of, this one is the 10th largest by enrollment, is one of 3 that started in 2017, is one of 14 with no phase, and was the 5th registered.
346 studies on the registry are indexed under Gait Disorders, Neurologic; 54 are open to participants now.
Browse Gait Disorders, Neurologic studies →3 of the 15 studies in Gait Disorders, Neurologic with a site in Korea, Republic of are open now. Recruiting first, the newest first:
Yonsei University · Sites in Korea, Republic of
Ages 7–18
Yonsei University · Sites in Korea, Republic of
Ages 19–79
Yonsei University · Sites in Korea, Republic of
Ages 19+
A study can be open while its sites in Korea, Republic of have not opened yet or have stopped. Only those recruiting at a site in Korea, Republic of →
Of the 36 Gait Disorders, Neurologic studies recruiting now, 14 (39%) set no upper age limit and 19 (53%) stop at 75 or younger; 5 take children under 18; 5 take healthy volunteers.
This study: 65 Years to 84 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2013; this study’s year is marked. 3 started in 2017.
This study's enrollment of 15 is below the median of 30 across 261 interventional studies indexed under Gait Disorders, Neurologic.
Median enrollment 22 across the 15 interventional studies. Of the 10 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
1 of 15 have an industry lead sponsor. The 6 most frequent:
Samsung Medical Center is the lead sponsor of 1,011 studies on the registry; 152 are open to participants now.
Of its 7 completed or terminated interventional studies of FDA-regulated products, 1 (14%) have results posted.
Samsung Medical Center has 5 studies filed under Gait Disorders, Neurologic — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 15 studies in Gait Disorders, Neurologic with a site in Korea, Republic of, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The aim of this study was to identify the assistance effect of the new wearable hip assist robot, gait enhancing mechatronic system (GEMS) developed by Samsung Advanced Institute of Technology (Samsung Electronics Co, Ltd., Korea) during stair ascent by comparing the energy expenditure of elderly adults with and without the GEMS.
Primary objective of this study is to demonstrate the effect of a wearable hip assist robot on cardiopulmonary metabolic efficiency during stair ascent in elderly adults.
Fifteen elderly adults participated in this study. The stair ascent trials were designed to climb stairs from the first basement level to the fourth floor of the Proton Therapy Center, Samsung Medical Center, Korea. The metabolic energy expenditure was measured using a portable cardiopulmonary metabolic system (Cosmed K4b², Rome, Italy) while participants performed randomly assigned two different conditions consecutively:, free ascent without the GEMS (NoGEMS) or robot-assisted ascent with the GEMS (GEMS). Participants rested for 10 minutes between the two trial conditions.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Stair climbing with and without a wearable hip assist robot
Device: Wearable hip assist robot
All participants climbed stairs from the first basement level to the fourth floor of the Proton Therapy Center, Samsung Medical Center, Korea with and without a wearable hip assist robot. During climbing stairs, the metabolic energy expenditure of all participants was measured using a portable cardiopulmonary metabolic system (Cosmed K4b², Rome, Italy).
Change on metabolic energy expenditure in GEMS condition compared with NoGEMS condition
All participants stood in a comfortable position for 5 minutes to obtain baseline variables before stair ascent. Participants were then asked to climb stairs from the first basement level to the fourth floor of the Proton Therapy Center, Samsung Medical Center, Korea, in a step-over-step manner under two different conditions, GEMS and NoGEMS. The GEMS and NoGEMS conditions were conducted in a random order, and just before the second condition, participants stood for 2～3 minutes to obtain baseline variables once more.
Time frame: 1 hour
Plan to share: No
Ran from Oct 2017 to primary completion in Nov 2017, 0 months.
Of 184 non-industry interventional studies with no phase under Gait Disorders, Neurologic, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 38. This study's 0 months is below that.
Counting every sponsor, half of 197 studies reached it within 14 months; a quarter within 5 and three quarters within 38.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.